ENHANCED EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 (TIMP-2) IN THE STROMA OF BREAST CARCINOMAS CORRELATES WITH TUMOR RECURRENCE

被引:162
作者
VISSCHER, DW
HOYHTYA, M
OTTOSEN, SK
LIANG, CM
SARKAR, FH
CRISSMAN, JD
FRIDMAN, R
机构
[1] WAYNE STATE UNIV,SCH MED,DEPT PATHOL,DETROIT,MI 48201
[2] UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND
[3] UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND
[4] ONCOLOGIX INC,GAITHERSBURG,MD 20878
关键词
D O I
10.1002/ijc.2910590308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The 72-kDa (MMP-2, gelatinase A) and the 92-kDa (MMP-9, gelatinase B) matrix metalloproteinases have been associated with tumor cell invasion and metastasis. Immunohistological staining of MMP-2 and MMP-9, basal lamina collagen IV and TIMP-2 were performed on frozen sections of 83 invasive breast carcinomas. MMP-2 and MMP-9 were associated with neoplastic cell plasma membrane in 72% of cases and exhibited inter-tumoral variability of staining intensity. MMP-2 and MMP-9 staining was not correlated with presence of metastases at time of diagnosis or with disease outcome. TIMP-2 was detected in the peri-tumoral stroma and was present in 87% of cases. Residual benign breast tissue was negative for TIMP-2 staining. Neoplasms with diffuse TIMP-2 staining (24%) recurred significantly more frequently (75% recurred) than cases with focal (42% recurred) or absent (27% recurred) TIMP-2. Presence of collagen IV was negatively correlated with gelatinase staining. We conclude that up-regulation of MMP-2 and MMP-9 expression in breast tumor cells is reciprocally correlated to collagen IV staining. Clinical outcome, however, is more closely related to the presence of TIMP-2 than the corresponding MMPs. Enhanced TIMP-2 expression, therefore, may denote a stromal response to tumor invasion, indicative of aggressive behavior in a subset of breast carcinomas. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 23 条
[1]  
AUTIOHARMAINEN H, 1993, LAB INVEST, V69, P312
[2]   A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS [J].
BASSET, P ;
BELLOCQ, JP ;
WOLF, C ;
STOLL, I ;
HUTIN, P ;
LIMACHER, JM ;
PODHAJCER, OL ;
CHENARD, MP ;
RIO, MC ;
CHAMBON, P .
NATURE, 1990, 348 (6303) :699-704
[3]  
BOAG AH, 1994, AM J PATHOL, V144, P585
[4]   EXPRESSION OF ACTIVATED GELATINASE IN HUMAN INVASIVE BREAST-CARCINOMA [J].
BROWN, PD ;
BLOXIDGE, RE ;
ANDERSON, E ;
HOWELL, A .
CLINICAL & EXPERIMENTAL METASTASIS, 1993, 11 (02) :183-189
[5]   ACTIVITY OF TYPE-IV COLLAGENASES IN BENIGN AND MALIGNANT BREAST DISEASE [J].
DAVIES, B ;
MILES, DW ;
HAPPERFIELD, LC ;
NAYLOR, MS ;
BOBROW, LG ;
RUBENS, RD ;
BALKWILL, FR .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1126-1131
[6]  
DAVIES B, 1993, CANCER RES, V53, P5365
[7]  
DERRICO A, 1991, MODERN PATHOL, V4, P239
[8]  
EMONARD HP, 1992, CANCER RES, V52, P5845
[9]   EXPRESSION OF HUMAN RECOMBINANT 72-KDA GELATINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 (TIMP-2) - CHARACTERIZATION OF COMPLEX AND FREE ENZYME [J].
FRIDMAN, R ;
BIRD, RE ;
HOYHTYA, M ;
OELKUCT, M ;
KOMAREK, D ;
LIANG, CM ;
BERMAN, ML ;
LIOTTA, LA ;
STETLERSTEVENSON, WG ;
FUERST, TR .
BIOCHEMICAL JOURNAL, 1993, 289 :411-416
[10]  
GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583